111 related articles for article (PubMed ID: 9597575)
21. CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devices.
McNiece IK; Stoney GB; Kern BP; Briddell RA
J Hematother; 1998 Oct; 7(5):457-61. PubMed ID: 9829320
[TBL] [Abstract][Full Text] [Related]
22. T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cells.
Olivero S; Novakovitch G; Ladaique P; Sainty D; Viret F; Faucher C; Stoppa AM; Blaise D; Chabannon C
Cytotherapy; 1999; 1(6):469-77. PubMed ID: 20443236
[TBL] [Abstract][Full Text] [Related]
23. Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: a pilot study.
Mapara MY; Körner IJ; Lentzsch S; Krahl D; Reichardt P; Dörken B
Exp Hematol; 1999 Jan; 27(1):169-75. PubMed ID: 9923456
[TBL] [Abstract][Full Text] [Related]
24. Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems.
Paulus U; Dreger P; Viehmann K; von Neuhoff N; Schmitz N
Stem Cells; 1997; 15(4):297-304. PubMed ID: 9253114
[TBL] [Abstract][Full Text] [Related]
25. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device.
Schumm M; Lang P; Taylor G; Kuçi S; Klingebiel T; Bühring HJ; Geiselhart A; Niethammer D; Handgretinger R
J Hematother; 1999 Apr; 8(2):209-18. PubMed ID: 10349915
[TBL] [Abstract][Full Text] [Related]
26. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
27. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
29. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
[TBL] [Abstract][Full Text] [Related]
30. Impact of leukapheresis cell composition on immunomagnetic cell selection with the Baxter Isolex 300i device: a statistical analysis.
Perotti C; Del Fante C; Viarengo GL; Bergamaschi P; Tinelli C; Bellotti L; Marchesi A; Parisi C; Salvaneschi L
Stem Cells Dev; 2004 Aug; 13(4):350-6. PubMed ID: 15345128
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
32. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
Bone Marrow Transplant; 1997 Sep; 20(5):415-20. PubMed ID: 9339759
[TBL] [Abstract][Full Text] [Related]
33. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results.
Martín-Henao GA; Picón M; Amill B; Querol S; González JR; Martínez C; Martino R; Ferrá C; Brunet S; Grañena A; Sierra J; García J
Transfusion; 2000 Jan; 40(1):35-43. PubMed ID: 10644809
[TBL] [Abstract][Full Text] [Related]
34. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
35. A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections.
Stainer CJ; Miflin G; Anderson S; Davy B; McQuaker IG; Russell NH
J Hematother; 1998 Aug; 7(4):375-83. PubMed ID: 9735869
[TBL] [Abstract][Full Text] [Related]
36. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
Statkute L; Verda L; Oyama Y; Traynor A; Villa M; Shook T; Clifton R; Jovanovic B; Satkus J; Loh Y; Quigley K; Yaung K; Gonda E; Krosnjar N; Spahovic D; Burt RK
Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo expansion and clonality of CD34+ selected cells from bone marrow and cord blood in a serum-free media.
Kim SK; Koh SK; Song SU; Shin SH; Choi GS; Kim WC; Lee MH; Seoh JY; Park SK; Fraser JK
Mol Cells; 2002 Dec; 14(3):367-73. PubMed ID: 12521299
[TBL] [Abstract][Full Text] [Related]
38. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
39. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C; Carlo-Stella C; Wagner JE; Mangoni L; Garau D; Re A; Giachetti R; Cesana C; Rizzoli V
Bone Marrow Transplant; 1997 Jun; 19(11):1079-84. PubMed ID: 9193749
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia.
Dreger P; Viehmann K; von Neuhoff N; Krüss D; Glass B; Kneba M; Mitsky P; Jopp P; Rautenberg P; Mills B; Schmitz N
Exp Hematol; 2000 Oct; 28(10):1187-96. PubMed ID: 11027838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
